Drug Shortage Report for MYLAN-MIRTAZAPINE

Last updated on 2023-07-14 History
Report ID 182205
Drug Identification Number 02256118
Brand name MYLAN-MIRTAZAPINE
Common or Proper name MIRTAZAPINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) MIRTAZAPINE
Strength(s) 30MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-03-08
Actual start date 2023-03-02
Estimated end date 2023-07-04
Actual end date 2023-07-04
Shortage status Resolved
Updated date 2023-07-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-01-23 English Compare
v2 2023-01-23 French Compare
v3 2023-02-06 English Compare
v4 2023-02-06 French Compare
v5 2023-03-07 English Compare
v6 2023-03-07 French Compare
v7 2023-05-08 English Compare
v8 2023-05-08 French Compare
v9 2023-05-16 English Compare
v10 2023-05-16 French Compare
v11 2023-05-31 English Compare
v12 2023-05-31 French Compare
v13 2023-06-13 English Compare
v14 2023-06-13 French Compare
v15 2023-07-08 English Compare
v16 2023-07-08 French Compare
v17 2023-07-14 English Compare
v18 2023-07-14 French Compare

Showing 1 to 18 of 18